Literature DB >> 4117261

Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction.

A Drapkin, C Merskey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4117261     DOI： 10.1001/jama.222.5.541

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

Review 1.  Prevention of cardioembolic stroke.

Authors:  William David Freeman; Maria I Aguilar
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

Review 2.  Therapeutic ranges for oral anticoagulation in different thromboembolic disorders.

Authors:  L Poller
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

Review 3.  Anticoagulants in older patients. A safety perspective.

Authors:  R J Beyth; C S Landefeld
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 4.  Anticoagulation and the heart.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

Review 5.  Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation.

Authors:  J R Stratton
Journal:  West J Med       Date:  1989-08

6.  Thrombosis: its role and prevention in cardiovascular events-Part II.

Authors:  L A Harker; A R Thompson; J M Harlan
Journal:  West J Med       Date:  1981-04

7.  [Autologous 131J-tagged human fibrinogen for early detection of venous thrombosis (preparation, biological and in vivo properties) (author's transl)].

Authors:  T Wuppermann; K Sippel; H Dahlgrün
Journal:  Klin Wochenschr       Date:  1978-05-01

8.  Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.

Authors:  R Collins; S MacMahon; M Flather; C Baigent; L Remvig; S Mortensen; P Appleby; J Godwin; S Yusuf; R Peto
Journal:  BMJ       Date:  1996-09-14

9.  Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction.

Authors:  Marianne K Kringen; Kari Bente Foss Haug; Runa M Grimholt; Camilla Stormo; Sigrid Narum; Mimi S Opdal; Jan Toralf Fosen; Armin P Piehler; Per W Johansen; Ingebjørg Seljeflot; Jens Petter Berg; Odd Brørs
Journal:  J Biomed Biotechnol       Date:  2010-11-24

Review 10.  Long-term anticoagulation. Indications and management.

Authors:  B M Stults; W H Dere; T H Caine
Journal:  West J Med       Date:  1989-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.